BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 019748
(336 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
Length = 306
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 40/134 (29%), Positives = 68/134 (50%), Gaps = 19/134 (14%)
Query: 27 ILESLFLVESDHMPSKSYIKTLKGRDLDNSLRSRAVSSILQFS----CKFDPFLSYLAVN 82
+L+SL +E ++P SY + ++ R++ +R +L+ C+ + F LA+N
Sbjct: 41 VLQSLLRLEERYVPRASYFQCVQ-REIKPHMRKMLAYWMLEVCEEQRCEEEVF--PLAMN 97
Query: 83 YMDRYLSSQEMPQPKPWKLRLLAVSCFSLAAKMRQIEFSYTQFQADGGLIFDTQTI---- 138
Y+DRYLS +P K +L+LL C LA+K+R+ T + I+ +
Sbjct: 98 YLDRYLSC--VPTRKA-QLQLLGAVCMLLASKLRET----TPLTIEKLCIYTDHAVSPRQ 150
Query: 139 -QRMECLILGALKW 151
+ E L+LG LKW
Sbjct: 151 LRDWEVLVLGKLKW 164
>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
Length = 283
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 13/82 (15%)
Query: 78 YLAVNYMDRYLSSQEMPQPKPWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGL 131
YLA ++ DRY+++QE L+L+ +S +AAK+ +I +F+Y DG
Sbjct: 72 YLAQDFFDRYMATQENVVKT--LLQLIGISSLFIAAKLEEIYPPKLHQFAYV---TDGAC 126
Query: 132 IFDTQTIQRMECLILGALKWRM 153
D I ME +I+ ALKWR+
Sbjct: 127 SGD--EILTMELMIMKALKWRL 146
>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 264
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 80
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 81 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLAF 134
Query: 152 RM 153
+
Sbjct: 135 DL 136
>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 18/120 (15%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 80
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 81 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLTF 134
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 18/147 (12%)
Query: 15 LFNDDDEDSTETILESLFLVESDHMPSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKF 72
L +++ D E I L +E P Y+K K D+ NS+R+ V +++ K
Sbjct: 3 LGSNEVPDYHEDIHTYLREMEVKCKPKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKL 60
Query: 73 DPFLSYLAVNYMDRYLSSQEMPQPKPWKLRLLAVSCFSLAAKMRQI------EFSYTQFQ 126
+LAVNY+DR+LSS + + KL+L+ + LA+K +I EF Y
Sbjct: 61 QNETLHLAVNYIDRFLSSMSVLR---GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDD 117
Query: 127 ADGGLIFDTQTIQRMECLILGALKWRM 153
+ + + RME L+L L + +
Sbjct: 118 T-----YTKKQVLRMEHLVLKVLTFDL 139
>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
Length = 269
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 80
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 81 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLAF 134
Query: 152 RM 153
+
Sbjct: 135 DL 136
>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
Length = 268
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 80
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 81 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLAF 134
Query: 152 RM 153
+
Sbjct: 135 DL 136
>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
Length = 262
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 80
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 81 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLAF 134
Query: 152 RM 153
+
Sbjct: 135 DL 136
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 261
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 24 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 79
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 80 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLTF 133
Query: 152 RM 153
+
Sbjct: 134 DL 135
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 80
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 81 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLAF 134
Query: 152 RM 153
+
Sbjct: 135 DL 136
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 80
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 81 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLAF 134
Query: 152 RM 153
+
Sbjct: 135 DL 136
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 80
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 81 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLTF 134
Query: 152 RM 153
+
Sbjct: 135 DL 136
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 18/120 (15%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 21 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 76
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 77 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLTF 130
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 260
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 23 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 78
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 79 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLTF 132
Query: 152 RM 153
+
Sbjct: 133 DL 134
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 18/120 (15%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 80
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 81 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLTF 134
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 18/120 (15%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 22 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 77
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 78 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLTF 131
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 18/120 (15%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 23 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 78
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 79 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLTF 132
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 18/120 (15%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 19 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 74
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 75 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLTF 128
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 18/120 (15%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K K D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 21 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 76
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 77 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YTKKQVLRMEHLVLKVLTF 130
>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 271
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 54/95 (56%), Gaps = 10/95 (10%)
Query: 27 ILESLFLVESDHMPSKSYIKTLKGRDLDNSLRSRAVSSILQF----SCKFDPFLSYLAVN 82
+L ++ E PS SY K ++ +++ S+R + +L+ C+ + F LA+N
Sbjct: 27 VLRAMLKAEETCAPSVSYFKCVQ-KEVLPSMRKIVATWMLEVCEEQKCEEEVF--PLAMN 83
Query: 83 YMDRYLSSQEMPQPKPWKLRLLAVSCFSLAAKMRQ 117
Y+DR+LS + + K +L+LL +C +A+KM++
Sbjct: 84 YLDRFLSLEPV---KKSRLQLLGATCMFVASKMKE 115
>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 257
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 54/95 (56%), Gaps = 10/95 (10%)
Query: 27 ILESLFLVESDHMPSKSYIKTLKGRDLDNSLRSRAVSSILQF----SCKFDPFLSYLAVN 82
+L ++ E PS SY K ++ +++ S+R + +L+ C+ + F LA+N
Sbjct: 13 VLRAMLKAEETCAPSVSYFKCVQ-KEVLPSMRKIVATWMLEVCEEQKCEEEVF--PLAMN 69
Query: 83 YMDRYLSSQEMPQPKPWKLRLLAVSCFSLAAKMRQ 117
Y+DR+LS + + K +L+LL +C +A+KM++
Sbjct: 70 YLDRFLSLEPV---KKSRLQLLGATCMFVASKMKE 101
>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 261
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/122 (28%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K + D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 24 PKVGYMK--RQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 79
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 80 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YSKKQVLRMEHLVLKVLAF 133
Query: 152 RM 153
+
Sbjct: 134 DL 135
>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 258
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/122 (28%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K + D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 21 PKVGYMK--RQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 76
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 77 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YSKKQVLRMEHLVLKVLAF 130
Query: 152 RM 153
+
Sbjct: 131 DL 132
>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 257
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/122 (28%), Positives = 59/122 (48%), Gaps = 18/122 (14%)
Query: 40 PSKSYIKTLKGRDLDNSLRSRAVSSILQFS--CKFDPFLSYLAVNYMDRYLSSQEMPQPK 97
P Y+K + D+ NS+R+ V +++ K +LAVNY+DR+LSS + +
Sbjct: 21 PKVGYMK--RQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLR-- 76
Query: 98 PWKLRLLAVSCFSLAAKMRQI------EFSYTQFQADGGLIFDTQTIQRMECLILGALKW 151
KL+L+ + LA+K +I EF Y + + + RME L+L L +
Sbjct: 77 -GKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDT-----YSKKQVLRMEHLVLKVLAF 130
Query: 152 RM 153
+
Sbjct: 131 DL 132
>pdb|1G7O|A Chain A, Nmr Solution Structure Of Reduced E. Coli Glutaredoxin 2
Length = 215
Score = 29.6 bits (65), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 22/75 (29%), Positives = 32/75 (42%), Gaps = 8/75 (10%)
Query: 1 MDFSLENPFTNFHELFNDDDEDSTETILESLFLV----ESDHMPSK----SYIKTLKGRD 52
M F L+N H L NDD E T + + + +S +MP Y+ L G+
Sbjct: 17 MIFGLKNIPVELHVLLNDDAETPTRMVGQKQVPILQKDDSRYMPESMDIVHYVDKLDGKP 76
Query: 53 LDNSLRSRAVSSILQ 67
L RS A+ L+
Sbjct: 77 LLTGKRSPAIEEWLR 91
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.133 0.389
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 7,211,839
Number of Sequences: 62578
Number of extensions: 221475
Number of successful extensions: 459
Number of sequences better than 100.0: 29
Number of HSP's better than 100.0 without gapping: 1
Number of HSP's successfully gapped in prelim test: 28
Number of HSP's that attempted gapping in prelim test: 457
Number of HSP's gapped (non-prelim): 29
length of query: 336
length of database: 14,973,337
effective HSP length: 99
effective length of query: 237
effective length of database: 8,778,115
effective search space: 2080413255
effective search space used: 2080413255
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 52 (24.6 bits)